Stem Cell Heart Therapy Standoff in Germany

BioMed Central reports on the debate over administering working stem cell therapies for heart damage in Germany. Oddly enough, given current restrictive Germany legislation, work appears to be progressing further in Germany than in the US. Here, the FDA simply stepped in to block treatments and human trials. Studies and human trials in the US, Japan and Germany have shown that this therapy works extraordinarily well; it saves lives that would otherwise be lost to heart disease, damage or failure. Despite this evidence, German and US government regulatory bodies are still blocking or attempting to block human trials.



Post a comment; thoughtful, considered opinions are valued. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.